Opendata, web and dolomites

CaReSyAn SIGNED

Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CaReSyAn project word cloud

Explore the words cloud of the CaReSyAn project. It provides you a very rough idea of what is the project "CaReSyAn" about.

academia    proteomics    vessels    disease    technologies    innovative    chronic    bioinformatics    cornerstone    combatting    deaths    cardiovascular    bridge    caresyan    business    basic    extremely    burden    vitro    career    mechanistic    animals    methodically    crs    exposure    environments    45    molecular    patient    services    syndrome    generate    ckd    ongoing    scientific    scientists    kidneys    complementary    excellent    technological    kidney    close    socio    successfully    academic    cooperations    cvd    clinical    skills    diseases    therapy    synergistically    experimental    trained    structural    functional    extend    broadly    cardiorenal    caused    nurture    personal    exactly    sme    solely    programs    killer    pathology    insights    cohorts    translation    integrating    disorders    heart    bridges    entrepreneurs    diagnosis    train    cooperation    strives    bioinformatical    century    young    patients    integrate    disciplinary    industry    treatment    training    economic    builds   

Project "CaReSyAn" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAETSKLINIKUM AACHEN 

Organization address
address: Pauwelsstrasse 30
city: AACHEN
postcode: 52074
website: www.ukaachen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 2˙795˙346 €
 EC max contribution 2˙795˙346 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAETSKLINIKUM AACHEN DE (AACHEN) coordinator 747˙649.00
2    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 263˙659.00
3    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 262˙875.00
4    RD NEPHROLOGIE SAS FR (MONTPELLIER) participant 262˙875.00
5    MEDIZINISCHE UNIVERSITAET WIEN AT (WIEN) participant 255˙934.00
6    DSM MATERIALS SCIENCE CENTER BV NL (GELEEN) participant 255˙374.00
7    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 255˙374.00
8    MOSAIQUES DIAGNOSTICS GMBH DE (HANNOVER) participant 249˙216.00
9    IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON EL (ATHINA) participant 242˙386.00
10    DSM R & D SOLUTIONS BV NL (SITTARD) participant 0.00
11    "EUTox, working group of the ""European Society of Artificial Organs"" (ESAO)" AT (Krems) partner 0.00
12    Bayer Pharma AG DE (Berlin) partner 0.00
13    Fresenius Medical Care Deutschland GmbH DE (BAD HOMBURG) partner 0.00
14    INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ ES (MADRID) partner 0.00
15    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) partner 0.00

Map

 Project objective

Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accomplish exactly this: we will train scientists to successfully integrate proteomics, clinical, experimental and bioinformatical analyses to enhance the understanding, diagnosis and therapy of the cardiorenal syndrome (CRS). CRS comprises disorders of the heart, vessels and kidneys, including the increased development of cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). With ~45% of all deaths in CKD patients caused by CVD, the socio-economic burden of CRS is extremely high.

CaReSyAn will train scientists in a close cooperation between academia, SME and industry partners. Key objectives are to provide: 1) Excellent scientific training on CRS pathology, integrating clinical/mechanistic knowledge with technological skills (animals and in vitro, molecular and functional studies, proteomics and bioinformatics) to generate innovative insights triggering the understanding, diagnosis and treatment of the CRS; 2) Excellent complementary skills in personal and career development as well as business training required to extend beyond scientific research; and 3) Exposure to both academic and non-academic environments, required to build bridges between researchers and entrepreneurs and support the future translation of research findings in innovative products and services. CaReSyAn builds on already available patient cohorts, advanced technologies and established cooperations. CaReSyAn is complementary to ongoing European programs focusing solely on CKD or CVD and strives to synergistically improve structural training on European level. CaReSyAn will nurture the development of young, broadly-trained scientists able to successfully bridge clinical with basic research as well as academia and industry. This is a cornerstone in effectively combatting complex diseases as CRS, a major killer of this century.

 Publications

year authors and title journal last update
List of publications.
2019 Eleni Petra, Jerome Zoidakis, Antonia Vlahou
Protein biomarkers for cardiorenal syndrome
published pages: 325-336, ISSN: 1478-9450, DOI: 10.1080/14789450.2019.1592682
Expert Review of Proteomics 16/4 2020-04-09
2019 Tianlin He
Implementation of Proteomics in Clinical Trials
published pages: 1800198, ISSN: 1862-8346, DOI: 10.1002/prca.201800198
PROTEOMICS – Clinical Applications 13/2 2020-04-09
2019 Sam Hobson, Samsul Arefin, Karolina Kublickiene, Paul Shiels, Peter Stenvinkel
Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease—A Novel Target for Treatment
published pages: 82, ISSN: 2072-6651, DOI: 10.3390/toxins11020082
Toxins 11/2 2020-04-09
2019 Julie Klein, Joost P Schanstra
Implementation of Proteomics Biomarkers in Nephrology: From Animal Models to Human Application?
published pages: 1800089, ISSN: 1862-8346, DOI: 10.1002/prca.201800089
PROTEOMICS – Clinical Applications 13/2 2020-04-09

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARESYAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARESYAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

EAGRE (2020)

Eagre/Aegir: high-seas wave-impact modelling

Read More  

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More  

ApPEARS (2019)

Appearance Printing - European Advanced Research School

Read More